Early Diagnosis of Systemic Scleroderma

Simple item page
dc.creatorSaidovna, Khamroeva Yulduz
dc.date2022-07-05
dc.date.accessioned2023-08-21T13:12:45Z
dc.date.available2023-08-21T13:12:45Z
dc.descriptionSystemic scleroderma (SSD) is an autoimmune disease, which is based on generalized microangiopathy and activation of the processes fibrosis of the skin and internal organs. Most patients develop visceral complications, which usually cause death. SSD are often diagnosed late, when pathological changes in organs are irreversible, and treatment is less effective. At the same time, the results of a large study showed that the mortality rate of patients with SSD reaches 68 per 1000 people per year. So, timely diagnosis of SSD is a difficult, but very important task for a doctor.en-US
dc.formatapplication/pdf
dc.identifierhttps://procedia.online/index.php/engineering/article/view/52
dc.identifier.urihttp://dspace.umsida.ac.id/handle/123456789/23775
dc.languageeng
dc.publisherPROCEDIA PUBLISH GROUPen-US
dc.relationhttps://procedia.online/index.php/engineering/article/view/52/47
dc.sourceProcedia of Engineering and Medical Sciences; Vol. 1 (2022): Proceedings of the 1st Conference of "Healthcare & Life-Science Research"; 31-38en-US
dc.source2795-563X
dc.subjectSystemic sclerodermaen-US
dc.subjectdiagnosisen-US
dc.subjectRaynaud's syndromeen-US
dc.subjectsclerodactylyen-US
dc.titleEarly Diagnosis of Systemic Sclerodermaen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Procedia of Engineering and Medical Sciences